Annie Luetkemeyer, MD, professor of infectious diseases at UCSF, is an expert on the treatment of viral infections. Robert Wachter, MD, MHM, chair of the UCSF Department of Medicine, interviewed her about the evidence behind potential treatments for COVID-19 (including chloroquine/hydroxychloroquine, remdesivir, and others), as well as how to assess new and existing drugs in a pandemic.
Clinical
Treatment options for COVID-19: Dr. Annie Luetkemeyer
Clinical
-
COVID toes and seasonal chilblains share similar immune responses -
When can uncomplicated acute appendicitis in adults be treated nonoperatively? -
-
Biomarkers may indicate severity of COVID in children -
-
-
-
-
D-dimer unreliable for ruling out pulmonary embolism in COVID-19 -
Quality
-
-
-
-
-
Public Policy
-
-
Biden vaccine mandate rule could be ready within weeks -
-
-
Practice Management
-
-
Major insurers running billions of dollars behind on payments to hospitals and doctors -
Two Colorado nurses admit to stealing drugs from hospital patients -
-
-
Nurses ‘at the breaking point,’ consider quitting due to COVID issues: Survey -
-
Baylor gets restraining order against COVID-19 vaccine–skeptic doc -
-
From the Society
Video
-
Critical care and COVID-19: Dr. Matt Aldrich -
Treatment options for COVID-19: Dr. Annie Luetkemeyer -
Managing the COVID-19 isolation floor at UCSF Medical Center -
-
